2nd Joint EBOVAC1 & EBOVAC2 annual meeting

The second joint EBOVAC1 & EBOVAC2 annual meeting was held in Windsor on 14-16 November 2016. Over 100 participants from both consortia attended. It was the opportunity to share information on the progress and results of 2016 activities.

1st Joint EBOVAC1 & EBOVAC2 annual meeting

The first EBOVAC1 & EBOVAC2 annual meetings was held in Paris from 20th to 22th of January 2016 at Novotel Convention & Wellness, Roissy.

EBOVAC2 Kick-off meeting

The project kick-off meeting was held at the Biopark auditorium, Paris on the 12th of February 2015.

More than 50 participants attended with representatives from the whole consortium, IMI2 and invited participants.

Targeting Ebola

EBOVAC1 and EBOVAC2 presented a poster entitled “Development of a prophylactic Ebola Vaccine using and heterologous prime-boost regimen” at Targeting Ebola, Paris, 28-29 May 2015.

To view the poster, please click here

EBOVAC2 coordinator, Rodolphe Thiebaut, made a presentation concerning accelerated development of Ebola vaccines. After explaining the context and the challenges, he presented the current development pipeline of vaccine trials and the limitations of existing methodogies. He concluded by outlining perspectives for the future of Ebola vaccine development.


Rodolphe Thiébaut, Ebovac2 coordinator © Ebovac2


  • 13 November 2016

    The joint EBOVAC1 and EBOVAC2 annual meeting took place in Windsor, UK from 14-16 November 2016.

  • 22 April 2016

    EBOVAC1 has published their first report on Phase 1 data in the April 19th 2016 issue of JAMA

    Press release and more information

  • 04 April 2016

    The first subject was vaccinated on 30 March 2016 at the University of Nairobi, Kenya

  • 29 March 2016

    The 1st EBOVAC2 Newsletter is available!

  • 29 February 2016

    The first subject was randomized on 10 December 2016 at Makerere University in Uganda.

  • 29 February 2016

    The first subject was randomized at CHU Treichville in Côte d'Ivoire on 26 February 2016.

More news
  • Ebola: background

    What is Ebola?

  • Phase 2 trials

    Find out more about EBOVAC2 trials

  • Work programme

    EBOVAC2 is organised into 6 workpackages (WP)

  • Ebola+ programme

    Contributes to efforts to tackle a wide range of challenges in Ebola research